Ghost Tree Capital as of Dec. 31, 2022
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 35 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Cl A | 8.1 | $19M | 500k | 37.99 | |
| Axsome Therapeutics (AXSM) | 7.7 | $18M | 235k | 77.13 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 6.8 | $16M | 130k | 122.13 | |
| Apellis Pharmaceuticals (APLS) | 6.6 | $16M | 300k | 51.71 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 5.7 | $13M | 50k | 266.28 | |
| Amylyx Pharmaceuticals (AMLX) | 5.5 | $13M | 350k | 36.95 | |
| Cti Biopharma | 4.7 | $11M | 1.9M | 6.01 | |
| Seagen | 4.7 | $11M | 85k | 128.51 | |
| Iveric Bio | 4.1 | $9.6M | 450k | 21.41 | |
| Cogent Biosciences (COGT) | 3.9 | $9.2M | 800k | 11.56 | |
| Mirati Therapeutics | 3.9 | $9.1M | 200k | 45.31 | |
| Iovance Biotherapeutics (IOVA) | 3.5 | $8.3M | 1.3M | 6.39 | |
| Karuna Therapeutics Ord | 3.4 | $7.9M | 40k | 196.50 | |
| Vaxcyte (PCVX) | 3.3 | $7.7M | 160k | 47.95 | |
| Sarepta Therapeutics (SRPT) | 3.0 | $7.1M | 55k | 129.58 | |
| Astria Therapeutics (ATXS) | 2.9 | $6.7M | 450k | 14.89 | |
| Madrigal Pharmaceuticals (MDGL) | 2.5 | $5.8M | 20k | 290.25 | |
| Revance Therapeutics (RVNC) | 2.4 | $5.5M | 300k | 18.46 | |
| Miragen Therapeutics (VRDN) | 2.1 | $4.8M | 165k | 29.21 | |
| Akero Therapeutics (AKRO) | 2.0 | $4.7M | 85k | 54.80 | |
| Provention Bio | 1.8 | $4.2M | 400k | 10.57 | |
| Aerovate Therapeutics (AVTE) | 1.7 | $4.0M | 135k | 29.30 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $3.8M | 150k | 25.45 | |
| Viking Therapeutics (VKTX) | 1.2 | $2.8M | 300k | 9.40 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $2.6M | 225k | 11.48 | |
| Rapt Therapeutics (RAPT) | 1.1 | $2.5M | 125k | 19.80 | |
| Kezar Life Sciences | 1.0 | $2.4M | 340k | 7.04 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $2.2M | 100k | 22.19 | |
| Tarsus Pharmaceuticals (TARS) | 0.5 | $1.2M | 80k | 14.66 | |
| Aadi Bioscience (AADI) | 0.5 | $1.2M | 90k | 12.83 | |
| Prometheus Biosciences | 0.5 | $1.1M | 9.9k | 110.04 | |
| X4 Pharmaceuticals (XFOR) | 0.4 | $993k | 1.0M | 0.99 | |
| Blueprint Medicines (BPMC) | 0.4 | $876k | 20k | 43.80 | |
| Design Therapeutics (DSGN) | 0.4 | $850k | 83k | 10.26 | |
| Aeglea Biotherapeutics | 0.2 | $360k | 800k | 0.45 |
